MAIA
Maia Biotechnology : Increased Maximum Offering Price of Shares of Common Stock Issuable Under at Market Offering Agreement to $30 Mln
时间：2024-12-24 06:46:13 市场： 美股 综合
Maia Biotechnology Announces Director Participation in Recent Private Placement Closings
时间：2024-12-19 21:47:00 市场： 美股 综合
Maia Biotechnology Granted FDA Rare Pediatric Disease Designation for Thio as a Treatment for Pediatric High-Grade Gliomas
时间：2024-12-16 21:37:00 市场： 美股 综合
Maia Biotechnology Announces Private Placement of Approximately $950,000
时间：2024-12-10 07:00:00 市场： 美股 综合
Maia Biotechnology Announces Late-Breaking Abstract of Thio-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39TH Annual Meeting
时间：2024-11-05 22:45:00 市场： 美股 综合
Vlad Vitoc Reports 13.29% Stake in Maia Biotechnology Inc as of Oct 25 - SEC Filing
时间：2024-10-26 05:13:36 市场： 美股 综合